CD34 and acute lymphoblastic leukemia: Seegmiller (2009) also reported such an asynchronous expression in 37.5% (75/200) cases of B—ALL cases while Sharma (2016) and Jalal (2017) an asynchronous dual expression of CD34 and CD20 in 12% cases.